383655

Brief Profile

Dr. Ajith Kamath was the India Head of Pfizer’s Strategic Research Partnership, involved in External R&D Innovation. In this role he got closely associated with the Indian ecosystem of discovery and innovation and is currently bringing all his scientific knowledge and experience to guide Mestastop towards precise, achievable and focused scientific goals.

Dr. Ajith Kamath

Senior Scientific Advisor

Education: PhD, Biochemistry, IISc, Stanford, UT Austin
Location:Bangalore

Details

 Senior Director, Pfizer-US (18+ years),
  SVP, Jubilant Biosys,
  Executive Director, Mitra Biotech,

Mumbai Angels

Pudnaa

Developer

“Mestastop is charting a pioneering and much-needed path to early detection of metastasis. Such work is key to furthering mankind’s understanding of human health”

Dr. D.C Doval

Krishnan D

Developer

“If Mestastop can predict metastasis probability of primary cancer patients, that will be a game changer for doctors”

Dr. A. K Vaid

Doctor

Developer

“Mestastop provides a great opportunity at finding solutions to the unmet medical needs in cancer care”

Dr. A. Kamath

Pudnaa

Developer

“Concept-wise, it is a much-needed approach to address metastasis; looks very interesting and perhaps doable with Arnab’s keen interest and passion”

CIIE

Clifi sinto

Developer

“Mestastop platform will play an instrumental role in changing cancer treatment in India and the world around”